These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7267842)

  • 21. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of dopaminergic systems in gamma-hydroxybutyrate-induced electrocorticogram hypersynchronization in the rat.
    Godschalk M; Dzoljic MR; Bonta IL
    J Pharm Pharmacol; 1977 Oct; 29(10):605-8. PubMed ID: 21239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the locomotor response to amphetamine by corticosterone.
    Mormède P; Dulluc J; Cador M
    Ann N Y Acad Sci; 1994 Nov; 746():394-7. PubMed ID: 7825896
    [No Abstract]   [Full Text] [Related]  

  • 24. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of chronic haloperidol administration on the prolactinlowering actions of peribedil.
    Ravitz AJ; Moore KE
    J Pharm Pharmacol; 1977 Jun; 29(6):384-6. PubMed ID: 18585
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.
    Angrist B; Ain M; Rotrosen J; Gershon S; Halpern FS; Sachar EJ
    J Neural Transm; 1979; 44(4):249-62. PubMed ID: 458429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of piribedil on adrenergic neurotransmission.
    Laubie M; Schmitt H
    Eur J Pharmacol; 1978 Nov; 52(1):99-107. PubMed ID: 214315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat.
    Reid JL; Lewis PJ; Myers MG
    Neuropharmacology; 1975 Mar; 14(3):215-20. PubMed ID: 1134626
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
    Creese I
    Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the effects of amphetamine and a fluorinated analogue on locomotion and exploratory activity in the mouse.
    Dubin RE; Reiffenstein RJ; Baker GB; Coutts RT; Benderly A
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):681-5. PubMed ID: 4089192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral effects of amylin injected intracerebroventricularly in the rat.
    Clementi G; Valerio C; Emmi I; Prato A; Drago F
    Peptides; 1996; 17(4):589-91. PubMed ID: 8804066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
    Porreca F; Cowan A; Tallarida RJ
    Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset.
    Smith LA; Jackson MG; Bonhomme C; Chezaubernard C; Pearce RK; Jenner P
    Clin Neuropharmacol; 2000; 23(3):133-42. PubMed ID: 10895396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity.
    Kovács GL; de Wied D
    Eur J Pharmacol; 1978 Dec; 53(1):103-7. PubMed ID: 738353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors?
    Costentin J; Marçais H; Protais P; Schwartz JC
    Life Sci; 1977 Mar; 20(5):883-6. PubMed ID: 15714774
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of ibotenate pedunculopontine tegmental nucleus lesions on exploratory behaviour in the open field.
    Steiniger B; Kretschmer BD
    Behav Brain Res; 2004 May; 151(1-2):17-23. PubMed ID: 15084417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphetamine- type reinforcement by dopaminergic agonists in the rat.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1978 Jul; 58(3):289-96. PubMed ID: 98800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.